Home » Speakers

Speakers

6th Expanded Access Progammes World Congress 2024 Europe

Thursday 11th - Friday 12th April 2024

KEY INDUSTRY EXPERT SPEAKERS

ANNIE O’KEEFE MARTIN

Global Medical Governance Lead for Managed Access Programs and Rare Humanitarian Programs

Sanofi

NORA PÖNTYNEN

Global Medical Affairs

Boehringer Ingelheim International GmbH

GORDON LUNDIE

Executive Director, Market Access and Pricing

Gilead Sciences

Pedro Franco

Sr Director, Head, Europe Global Regulatory & Scientific Policy

Merck Healthcare

SHEELA UPADHYAYA

Chair Elect, Rare Disease Special Interest Group

ISPOR

PAUL BLAKELEY

Sr Policy Advisor, Health and Life Sciences

Tony Blair Institute for Global Change

DR JAMES DUBOFF

Strategic Partnerships Director

Genomics England

ROBERT MITCHELL-THAIN

CEO

PBC Foundation

Dr. Alberto Calabrò

Patient Access Program and Supply Leader

F. Hoffmann-La Roche Ltd

Senior Representative

Available Shortly

Available Shortly!

CAMERON MILLER

Director of Policy & Strategy

The Brain Tumour Charity

LINDSAY BIRREL

Co- CEO, Realise Advocacy, Chair of trustees

Medics 4 Rare Diseases

JULIE POWELL

Marketing & Communications Director

Pleco Therapeutics

JOSIE GODFREY

Co-Founder and CEO

Realise Advocacy

PR DANIEL SCHERMAN

Head of Medicine, Life Sciences Division

European Academy of Sciences EURASC

Katja Berg

Innovative Value and Access Strategy

AstraZeneca

Dr David Gillen,

Gillen, Chief Medical Officer

Norgine

Senior Representative

Head of Expanded Access

WEP Clinical

DR.DINESH KUMAR

International Medical Director, Medical Review & Compliance

Alnylam UK Ltd

Adam Jones

Head of Medical Affairs, International

Amicus Therapeutics

Scroll to Top